← Leaderboards
Shifa Turan
University Of Maryland Baltimore
$1,023,225
Attributed
$3,037,047
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $759K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,037,047 · 2
By mechanism
R01$3,020,733 · 1
R13$16,314 · 1
Top collaborators
- Wei-Bin Shen4 shared
- Peixin Yang4 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Peixin Yang$21,969,416
- Wei-Bin Shen$3,610,189
- Zhiyong Zhao$1,750,597
- Bradley K McConnell$3,958,411
- Aikaterini Kontrogianni-Konstantopoulos$13,265,718
Others in their field
Other Emerging Leaders on “Incidence”
- Yunda Huang · Fred Hutchinson Cancer Center$53,742,512
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,703,204
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Julie Ake · National Institute Of Allergy And Infectious Diseases$39,792,120
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420
Research focus
IncidenceWomanCardiogenesisHeart FunctionCongenital Heart DefectsCardiacEmbryonic HeartCardiac MyocytesEpigenetic MemoryDna Methylation ProfilingCellsCellular StressDnmt3b GeneEmbryoDna MethylationDna Modification MethylasesApoptosisCongenital AbnormalityComplexDefectCell ProliferationDiabetes MellitusDiabeticBinding
Grant awards (5)
Heightened hypoxia and DNA methylation in heart defects of diabetic embryopathy$758,978
R01 · FY2025 · HL
Heightened hypoxia and DNA methylation in heart defects of diabetic embryopathy$743,799
R01 · FY2024 · HL
Heightened hypoxia and DNA methylation in heart defects of diabetic embryopathy$758,978
R01 · FY2023 · HL
Heightened hypoxia and DNA methylation in heart defects of diabetic embryopathy$758,978
R01 · FY2022 · HL
2019 Second International Fetal Heart Symposium$16,314
R13 · FY2019 · HL · contact PI